Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CYSTINE TRYPTIC AGAR W/SUCROSE

K-Number: K844546 · 1985-01-16

ApplicantbioMerieux, Inc.
Decision Date1985-01-16
Product CodeJSF
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

CYSTINE TRYPTIC AGAR W/SUCROSE is the device name listed in this FDA 510(k) record. The listed applicant is bioMerieux, Inc.. It received FDA 510(k) clearance on 1985-01-16 under 510(k) number K844546. The device is classified under product code JSF. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CYSTINE TRYPTIC AGAR W/SUCROSE?

CYSTINE TRYPTIC AGAR W/SUCROSE is a medical device that received FDA 510(k) clearance on 1985-01-16. The listed applicant is bioMerieux, Inc.. The 510(k) number is K844546.

When did CYSTINE TRYPTIC AGAR W/SUCROSE receive FDA 510(k) clearance?

CYSTINE TRYPTIC AGAR W/SUCROSE received FDA 510(k) clearance on 1985-01-16, under 510(k) number K844546.

Who is the listed applicant for CYSTINE TRYPTIC AGAR W/SUCROSE?

The FDA 510(k) record lists bioMerieux, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CYSTINE TRYPTIC AGAR W/SUCROSE?

The FDA product code for CYSTINE TRYPTIC AGAR W/SUCROSE is JSF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing bioMerieux, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260160VITEK REVEAL GN AST Assay and VITEK REVEAL AST SystemK260282VITEK 2 AST-Streptococcus Inducible Clindamycin ResistanceK251579VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)K234012VITEK COMPACT PROK232967VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)K232963VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)

View all 248 devices →

Related Devices (Code: JSF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K880946NUTRIENT GELATIN - PRODUCT NUMBER T2860Lakewood Biochemical Co., Inc.K880119MOELLERS DECARBOXYLASE, ONITHINEHardy MediaK880126LAURYL TRYPTOSE BROTHHardy MediaK880120MOELLERS DECARBOXYLASE, LYSINEHardy MediaK880139ONPG TEST REAGENTHardy MediaK880113CYSTINE TRYPTIC MEDIUM W/LACTOSEHardy Media

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑